Acorda therapeutics announces completion of one-for-six reverse stock split

Ardsley, n.y.--(business wire)--acorda therapeutics, inc. (nasdaq: acor) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares of common stock. the reverse stock split became effective at 4:01 p.m. eastern time today, and the company's common stock will begin trading on a split-adjusted basis at the market open on january 4, 2021. the reverse stock split was effected in accordance with the authorization adopted by aco
ACOR Ratings Summary
ACOR Quant Ranking